The University of Oxford is set to begin trials for a new Ebola vaccine, which has been rapidly developed to combat the Bundibugyo strain currently devastating the Democratic Republic of Congo.
Scientists at the university will initially assess the safety and immune response of the jab in 50 healthy adults aged 18 to 55 in the UK.